Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...
including an effect on amyloid and tau. Another drug with a known mechanism of action, in the area of autoimmune diseases, is ...
TYK2 enzyme changes tau protein from a protective role to a harmful one, contributing to Alzheimer’s disease progression.
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital and collaborating institutions discovered that the enzyme ...
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...
Scientists have discovered that the enzyme TYK2 modifies tau proteins, leading to their accumulation in the brain—a key ...
Biogen Inc. has identified non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of cancer, autoimmune disease, cardiovascular disorders, fibrosis, inflammatory ...
Te Whare Wānanga o Waitaha | University of Canterbury lecturer Dr Kseniia Zahrai is the winner of the Early Career Researcher category in the Aotearoa Business and Economics Research Translation ...